Repurposing picropodophyllin as a potential thyroid eye disease treatment via delaying mitotic clonal expansion through a patient-derived preclinical platform

利用患者来源的临床前平台，通过延缓有丝分裂克隆扩增，将苦参碱重新用于潜在的甲状腺眼病治疗。